| P50 | author | Suzy A A Comhair | Q114735589 |
| P2093 | author name string | Viswanathan Natarajan | |
| | Shuangping Zhao | |
| | Roberto F Machado | |
| | Jiwang Chen | |
| | Justin R Sysol | |
| | Sunit Singla | |
| P2860 | cites work | Interaction of integrin β4 with S1P receptors in S1P- and HGF-induced endothelial barrier enhancement | Q24298045 |
| | The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 |
| | The functions of animal microRNAs | Q27860621 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts | Q37364840 |
| | Pathogenesis of pulmonary arterial hypertension: lessons from cancer | Q38167729 |
| | Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase | Q38342964 |
| | MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment | Q38347252 |
| | Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer | Q38828506 |
| | Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. | Q38927654 |
| | Antitumor activity of sphingosine kinase inhibitors | Q40288624 |
| | Pim-1: A new biomarker in pulmonary arterial hypertension | Q40303684 |
| | Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites | Q42419115 |
| | Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate | Q42556020 |
| | The cancer paradigm of severe pulmonary arterial hypertension | Q42682888 |
| | Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. | Q42746715 |
| | Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. | Q44565276 |
| | Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury | Q44799601 |
| | Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members | Q45211713 |
| | Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension. | Q46004739 |
| | BDNF/TrkB signaling augments smooth muscle cell proliferation in pulmonary hypertension | Q48339689 |
| | MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype. | Q50300330 |
| | MicroRNA-1 regulates the proliferation of vascular smooth muscle cells by targeting insulin-like growth factor 1. | Q50320379 |
| | Loss of epithelial Gq and G11 signaling inhibits TGFβ production but promotes IL-33-mediated macrophage polarization and emphysema. | Q51346034 |
| | Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. | Q51556854 |
| | Tanshinone IIA promotes pulmonary artery smooth muscle cell apoptosis in vitro by inhibiting the JAK2/STAT3 signaling pathway. | Q51730033 |
| | Role of Spm-Cer-S1P signalling pathway in MMP-2 mediated U46619-induced proliferation of pulmonary artery smooth muscle cells: protective role of epigallocatechin-3-gallate. | Q53305086 |
| | Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. | Q55040228 |
| | Pulmonary Arterial Hypertension | Q58485998 |
| | MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells | Q28282084 |
| | Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 |
| | Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation | Q28297726 |
| | Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 |
| | microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. | Q30090181 |
| | Pulmonary arterial hypertension: the clinical syndrome | Q30583630 |
| | MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension | Q32884516 |
| | Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis | Q33756825 |
| | Extracellular and Intracellular Actions of Sphingosine-1-Phosphate | Q34183703 |
| | MicroRNA-directed cleavage of targets: mechanism and experimental approaches | Q34389690 |
| | Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation | Q34447498 |
| | Adipocyte lipolysis-stimulated interleukin-6 production requires sphingosine kinase 1 activity | Q34509799 |
| | Circulating miRNAs as potential marker for pulmonary hypertension | Q34745818 |
| | Pervasive roles of microRNAs in cardiovascular biology | Q34775686 |
| | ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll | Q34977467 |
| | The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension | Q34986940 |
| | Mitochondrial dynamics in pulmonary arterial hypertension | Q35116543 |
| | Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development | Q35195495 |
| | MicroRNAs in pulmonary arterial hypertension | Q35207669 |
| | CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction | Q35279508 |
| | Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis | Q35573029 |
| | Role of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth Muscle | Q35698710 |
| | Treatment of pulmonary arterial hypertension | Q35905944 |
| | MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. | Q35955250 |
| | IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation | Q36083412 |
| | Hypoxia-induced migration in pulmonary arterial smooth muscle cells requires calcium-dependent upregulation of aquaporin 1 | Q36178060 |
| | Genomics of microRNA. | Q36381610 |
| | Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression | Q36520389 |
| | Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling | Q36873593 |
| | High levels of hyaluronan in idiopathic pulmonary arterial hypertension | Q36977316 |
| | PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation | Q37070994 |
| | Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. | Q37137690 |
| | Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins | Q37218785 |
| | MicroRNAs in pulmonary arterial remodeling | Q37308092 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | microRNA | Q310899 |
| | microvasculature remodeling | Q6840464 |
| P304 | page(s) | ajplung.00057.2017 | |
| P577 | publication date | 2017-11-22 | |
| P1433 | published in | American Journal of Physiology - Lung Cellular and Molecular Physiology | Q4352992 |
| P1476 | title | MicroRNA-1 Is Decreased by Hypoxia and Contributes to the Development of Pulmonary Vascular Remodeling via Regulation of Sphingosine Kinase 1. | |